Corporate profile
GlaxoSmithKline (GSK) is a leading global research-based pharmaceutical company with a powerful combination of skills and resources that provides a platform for delivering strong growth in today's rapidly changing healthcare environment.
GSK's mission is to improve the quality of human life by enabling people to do more, feel better and live longer.
Headquartered in the UK and with operations based in the US, the company is one of the industry leaders, with 6.3% per cent of the world's pharmaceutical market.
GSK has a leadership position in anti-infectives, respiratory and vaccines and has a growing portfolio of oncology products.
The company also has a Consumer Healthcare portfolio comprising over-the-counter (OTC) medicines, oral care products and nutritional healthcare drinks, all of which are among the market leaders.
GSK has over 100,000 employees in 116 countries. Of these, more than 34,000 employees work in manufacturing and over 15,000 are in R&D.
Back to top
GSK at a glance
We are the only pharmaceutical company to tackle the three "priority" diseases identified by the World Health Organization: HIV/AIDS, tuberculosis and malaria Our business employs over 100,000 people in 117 countries We make almost four billion packs of medicines and healthcare products every year We screen about 65 million compounds every year in our search for new medicines We supply one quarter of the world's vaccines and by the end of 2007 we had 23 vaccines in clinical development To date, we have donated over 750 million albendazole tablets to help elimitate lymphatic filariasis (elephantiasis) in the world In 2006 we shipped 126 million tablets of preferentially-priced Combivir and Epivir (our HIV treatments) to developing countries Almost 100 countries benefitted from our humanitarian product donations